Lifting weights alone moved blood sugar, insulin and waistlines in type 2 diabetes

Exercise advice for people with type 2 diabetes has traditionally led with aerobic work: walking, cycling, swimming. Yet many people cannot or will not do sustained cardio, and strength training is often treated as an optional extra rather than a treatment in its own right. That leaves an important question open: if resistance training is the only exercise someone does, does it meaningfully move the markers that drive diabetes complications, such as blood glucose, insulin, blood fats and waist size? This review set out to answer that question for adults living with both type 2 diabetes and excess weight, the group in whom these markers matter most.

The authors swept six databases from their start dates up to May 2024 for randomised trials comparing resistance training on its own against standard treatment with no exercise. Participants had to be adults with diagnosed type 2 diabetes and a body mass index of 25 or above. Eighteen trials qualified, covering 1180 patients with an average age of 63.3 years and a roughly even split of women and men. The pooled analysis examined waist measurements, blood lipids, fasting glucose and insulin, and glycated haemoglobin, the standard marker of longer-term blood sugar control.

Compared with standard treatment alone, resistance training improved a broad sweep of markers: waist circumference and waist-to-hip ratio shrank, HDL cholesterol rose, and triglycerides, fasting glucose, fasting insulin and glycated haemoglobin all fell. The improvements spanned both body shape and blood chemistry, which is notable for an intervention that involved no aerobic exercise at all. Every one of the seven reported outcomes moved in the favourable direction. That said, the certainty of the evidence ranged from very low to moderate, and the risk of bias in the underlying trials was rated low to unclear, so the precise sizes of these effects remain soft.

This analysis strengthens the case that strength training is a genuine standalone therapy for type 2 diabetes rather than a garnish on top of cardio. Previous guidance has tended to combine resistance work with aerobic exercise, making it hard to isolate what lifting alone contributes. By restricting inclusion to trials of resistance training versus no exercise, this review isolates that contribution directly. Open questions remain about the best programme design, how lifting compares with aerobic training head to head, and whether improvements in markers translate into fewer complications over years rather than months.

For anyone managing type 2 diabetes alongside excess weight, or simply watching their metabolic health, this is a reason to think time spent lifting counts as metabolic medicine, not just muscle building. The pooled trials suggest strength work on its own can shift blood sugar control, insulin, blood fats and waist size in the right direction. It is not evidence that weights beat cardio, and the mixed certainty of the underlying trials means the effect sizes should be held loosely. The findings say nothing about specific programmes, and treatment decisions sit with a person's own care team.